Koninklijke Philips N.V. (PHIA.AS)
EUR 24.19
(1.51%)
EUR 24.19
(1.51%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.49 Billion EUR | -13.78% |
| 2022 | 4.04 Billion EUR | 17.36% |
| 2021 | 3.45 Billion EUR | 15.27% |
| 2020 | 2.99 Billion EUR | 7.93% |
| 2019 | 2.77 Billion EUR | 3.7% |
| 2018 | 2.67 Billion EUR | 13.64% |
| 2017 | 2.35 Billion EUR | -30.63% |
| 2016 | 3.39 Billion EUR | -2.05% |
| 2015 | 3.46 Billion EUR | 4.5% |
| 2014 | 3.31 Billion EUR | 2.28% |
| 2013 | 3.24 Billion EUR | -7.3% |
| 2012 | 3.49 Billion EUR | -3.59% |
| 2011 | 3.62 Billion EUR | -6.21% |
| 2010 | 3.86 Billion EUR | 32.68% |
| 2009 | 2.91 Billion EUR | -13.59% |
| 2008 | 3.37 Billion EUR | 5.09% |
| 2007 | 3.2 Billion EUR | 11.38% |
| 2006 | 2.87 Billion EUR | -17.19% |
| 2005 | 3.47 Billion EUR | 7.76% |
| 2004 | 3.22 Billion EUR | 0.91% |
| 2003 | 3.19 Billion EUR | -9.27% |
| 2002 | 3.52 Billion EUR | -17.98% |
| 2001 | 4.29 Billion EUR | -18.82% |
| 2000 | 5.29 Billion EUR | 15.6% |
| 1999 | 4.57 Billion EUR | 7.74% |
| 1998 | 4.25 Billion EUR | -17.06% |
| 1997 | 5.12 Billion EUR | 3.19% |
| 1996 | 4.96 Billion EUR | -15.61% |
| 1995 | 5.88 Billion EUR | 19.95% |
| 1994 | 4.9 Billion EUR | 9.84% |
| 1993 | 4.46 Billion EUR | -6.48% |
| 1992 | 4.77 Billion EUR | 4.83% |
| 1991 | 4.55 Billion EUR | -8.97% |
| 1990 | 5 Billion EUR | -11.72% |
| 1989 | 5.66 Billion EUR | 5.34% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | - EUR | -100.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 3.61 Billion EUR | 0.0% |
| 2023 Q2 | 4.09 Billion EUR | 0.0% |
| 2023 Q4 | 3.49 Billion EUR | 0.0% |
| 2023 FY | 3.49 Billion EUR | -13.78% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q2 | 4.1 Billion EUR | 0.0% |
| 2022 FY | 4.04 Billion EUR | 17.36% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q4 | 4.04 Billion EUR | 0.0% |
| 2021 Q4 | 3.45 Billion EUR | 0.0% |
| 2021 FY | 3.45 Billion EUR | 15.27% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 3.22 Billion EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2020 FY | 2.99 Billion EUR | 7.93% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 3.19 Billion EUR | 0.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2020 Q4 | 2.99 Billion EUR | 0.0% |
| 2019 Q2 | 2.98 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q4 | 2.77 Billion EUR | 0.0% |
| 2019 FY | 2.77 Billion EUR | 3.7% |
| 2019 Q3 | - EUR | -100.0% |
| 2018 Q4 | 2.67 Billion EUR | 0.0% |
| 2018 FY | 2.67 Billion EUR | 13.64% |
| 2018 Q2 | 2.7 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q3 | 2.69 Billion EUR | 4.95% |
| 2017 FY | 2.35 Billion EUR | -30.63% |
| 2017 Q1 | 3.62 Billion EUR | 6.99% |
| 2017 Q2 | 2.56 Billion EUR | -29.35% |
| 2017 Q4 | 2.35 Billion EUR | -12.56% |
| 2016 Q2 | 3.68 Billion EUR | 2.42% |
| 2016 Q1 | 3.6 Billion EUR | 3.98% |
| 2016 Q4 | 3.39 Billion EUR | -9.76% |
| 2016 FY | 3.39 Billion EUR | -2.05% |
| 2016 Q3 | 3.75 Billion EUR | 1.93% |
| 2015 Q1 | 3.91 Billion EUR | 18.17% |
| 2015 FY | 3.46 Billion EUR | 4.5% |
| 2015 Q2 | 3.97 Billion EUR | 1.46% |
| 2015 Q4 | 3.46 Billion EUR | -13.66% |
| 2015 Q3 | 4.01 Billion EUR | 0.96% |
| 2014 Q1 | 3.44 Billion EUR | 6.45% |
| 2014 FY | 3.31 Billion EUR | 2.28% |
| 2014 Q2 | 3.63 Billion EUR | 5.48% |
| 2014 Q3 | 3.97 Billion EUR | 9.37% |
| 2014 Q4 | 3.31 Billion EUR | -16.71% |
| 2013 Q2 | 3.69 Billion EUR | 1.87% |
| 2013 Q4 | 3.24 Billion EUR | -15.45% |
| 2013 Q1 | 3.63 Billion EUR | 3.89% |
| 2013 FY | 3.24 Billion EUR | -7.3% |
| 2013 Q3 | 3.83 Billion EUR | 3.6% |
| 2012 Q4 | 3.49 Billion EUR | -14.15% |
| 2012 Q2 | 3.97 Billion EUR | 4.03% |
| 2012 Q1 | 3.81 Billion EUR | 5.35% |
| 2012 Q3 | 4.07 Billion EUR | 2.47% |
| 2012 FY | 3.49 Billion EUR | -3.59% |
| 2011 Q2 | 3.76 Billion EUR | 6.06% |
| 2011 Q1 | 3.54 Billion EUR | -8.28% |
| 2011 FY | 3.62 Billion EUR | -6.21% |
| 2011 Q3 | 4.07 Billion EUR | 8.35% |
| 2011 Q4 | 3.62 Billion EUR | -11.02% |
| 2010 Q3 | 4.15 Billion EUR | 5.8% |
| 2010 FY | 3.86 Billion EUR | 32.68% |
| 2010 Q4 | 3.86 Billion EUR | -7.0% |
| 2010 Q2 | 3.92 Billion EUR | 18.96% |
| 2010 Q1 | 3.3 Billion EUR | 13.35% |
| 2009 FY | 2.91 Billion EUR | -13.59% |
| 2009 Q3 | 3.29 Billion EUR | 2.49% |
| 2009 Q2 | 3.21 Billion EUR | -3.51% |
| 2009 Q1 | 3.33 Billion EUR | -1.13% |
| 2009 Q4 | 2.91 Billion EUR | -11.62% |
| 2008 Q1 | 3.71 Billion EUR | 15.81% |
| 2008 Q2 | 3.84 Billion EUR | 3.62% |
| 2008 Q3 | 4.16 Billion EUR | 8.1% |
| 2008 FY | 3.37 Billion EUR | 5.09% |
| 2008 Q4 | 3.37 Billion EUR | -18.99% |
| 2007 Q4 | 3.2 Billion EUR | -14.69% |
| 2007 Q2 | 3.36 Billion EUR | 8.3% |
| 2007 Q1 | 3.1 Billion EUR | 7.92% |
| 2007 FY | 3.2 Billion EUR | 11.38% |
| 2007 Q3 | 3.76 Billion EUR | 11.72% |
| 2006 FY | 2.87 Billion EUR | -17.19% |
| 2006 Q1 | 3.85 Billion EUR | 10.88% |
| 2006 Q3 | 3.43 Billion EUR | -12.3% |
| 2006 Q4 | 2.87 Billion EUR | -16.07% |
| 2006 Q2 | 3.91 Billion EUR | 1.48% |
| 2005 Q1 | 3.6 Billion EUR | 11.79% |
| 2005 Q4 | 3.47 Billion EUR | -13.45% |
| 2005 Q2 | 3.99 Billion EUR | 10.64% |
| 2005 FY | 3.47 Billion EUR | 7.76% |
| 2005 Q3 | 4.01 Billion EUR | 0.66% |
| 2004 Q4 | 3.22 Billion EUR | -20.4% |
| 2004 Q2 | 3.73 Billion EUR | 5.53% |
| 2004 Q1 | 3.53 Billion EUR | 10.65% |
| 2004 FY | 3.22 Billion EUR | 0.91% |
| 2004 Q3 | 4.05 Billion EUR | 8.58% |
| 2003 FY | 3.19 Billion EUR | -9.27% |
| 2003 Q4 | 3.19 Billion EUR | -17.3% |
| 2003 Q3 | 3.86 Billion EUR | 3.6% |
| 2003 Q2 | 3.73 Billion EUR | 0.6% |
| 2003 Q1 | 3.71 Billion EUR | 5.26% |
| 2002 Q1 | 4.44 Billion EUR | 3.5% |
| 2002 Q2 | 4.3 Billion EUR | -3.32% |
| 2002 Q3 | 4.52 Billion EUR | 5.34% |
| 2002 Q4 | 3.52 Billion EUR | -22.18% |
| 2002 FY | 3.52 Billion EUR | -17.98% |
| 2001 FY | 4.29 Billion EUR | -18.82% |
| 2001 Q4 | 4.29 Billion EUR | -22.01% |
| 2001 Q3 | 5.51 Billion EUR | -5.19% |
| 2001 Q2 | 5.81 Billion EUR | -1.63% |
| 2001 Q1 | 5.9 Billion EUR | 11.61% |
| 2000 Q3 | 5.76 Billion EUR | 12.23% |
| 2000 Q2 | 5.13 Billion EUR | 7.29% |
| 2000 Q1 | 4.78 Billion EUR | 4.51% |
| 2000 Q4 | 5.29 Billion EUR | -8.13% |
| 2000 FY | 5.29 Billion EUR | 15.6% |
| 1999 Q2 | 4.94 Billion EUR | 4.57% |
| 1999 Q4 | 4.57 Billion EUR | -9.31% |
| 1999 Q3 | 5.04 Billion EUR | 2.17% |
| 1999 Q1 | 4.72 Billion EUR | 11.2% |
| 1999 FY | 4.57 Billion EUR | 7.74% |
| 1998 FY | 4.25 Billion EUR | -17.06% |
| 1998 Q3 | 5.37 Billion EUR | 2.29% |
| 1998 Q2 | 5.25 Billion EUR | -8.6% |
| 1998 Q1 | 5.74 Billion EUR | 12.19% |
| 1998 Q4 | 4.25 Billion EUR | -20.93% |
| 1997 FY | 5.12 Billion EUR | 3.19% |
| 1997 Q4 | 5.12 Billion EUR | -17.54% |
| 1997 Q3 | 6.21 Billion EUR | 5.1% |
| 1997 Q2 | 5.91 Billion EUR | 6.16% |
| 1997 Q1 | 5.56 Billion EUR | 12.15% |
| 1996 Q4 | 4.96 Billion EUR | 0.0% |
| 1996 FY | 4.96 Billion EUR | -15.61% |
| 1995 Q4 | 5.88 Billion EUR | 0.0% |
| 1995 FY | 5.88 Billion EUR | 19.95% |
| 1994 FY | 4.9 Billion EUR | 9.84% |
| 1994 Q4 | 4.9 Billion EUR | 0.0% |
| 1993 FY | 4.46 Billion EUR | -6.48% |
| 1993 Q4 | 4.46 Billion EUR | 0.0% |
| 1992 Q4 | 4.77 Billion EUR | 0.0% |
| 1992 FY | 4.77 Billion EUR | 4.83% |
| 1991 FY | 4.55 Billion EUR | -8.97% |
| 1991 Q4 | 4.55 Billion EUR | 0.0% |
| 1990 FY | 5 Billion EUR | -11.72% |
| 1990 Q4 | 5 Billion EUR | 0.0% |
| 1989 Q4 | 5.66 Billion EUR | 0.0% |
| 1989 FY | 5.66 Billion EUR | 5.34% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Affluent Medical SA | - EUR | -Infinity% |
| Bluelinea Société Anonyme | 236.08 Thousand EUR | -1478592.177% |
| Carmat SA | 23.94 Million EUR | -14479.853% |
| Diagnostic Medical Systems S.A. | 16.04 Million EUR | -21664.339% |
| Euromedis Groupe | 10.8 Million EUR | -32201.786% |
| Eurobio Scientific Société anonyme | 21.44 Million EUR | -16175.817% |
| Ikonisys S.A. | 473.37 Thousand EUR | -737364.062% |
| Implanet S.A. | 3.78 Million EUR | -92254.497% |
| Median Technologies SA | 102 Thousand EUR | -3422449.02% |
| SpineGuard SA | 950.88 Thousand EUR | -367032.444% |
| Theraclion SA | 3.05 Million EUR | -114182.684% |
| Euroapi S.A. | 644.8 Million EUR | -441.408% |
| Guerbet SA | 309.51 Million EUR | -1027.883% |
| Ion Beam Applications SA | 168.98 Million EUR | -1965.815% |
| Sequana Medical NV | 2.29 Million EUR | -151968.696% |